Novavax - FDA Approves Transfer Of Nuvaxovid Authorization To Sanofi - SEC Filing

Reuters11-20

Nov 4 (Reuters) - Novavax Inc ::
*NOVAVAX INC - FDA APPROVES TRANSFER OF NUVAXOVID AUTHORIZATION TO SANOFI - SEC FILING
*NOVAVAX INC - NUVAXOVID MARKETING AUTHORIZATION TRANSFER TRIGGERS $25 MILLION PAYMENT FROM SANOFI TO NOVAVAX - SEC FILING
*NOVAVAX INC: ANTICIPATES RECEIPT OF MILESTONE PAYMENT FROM SANOFI IN Q1 OF 2026

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 04-NOV-202511:15:24 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2584592567?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-20 00:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584592567","market":"us","top_or_hot":-1,"title":"Novavax - FDA Approves Transfer Of Nuvaxovid Authorization To Sanofi - SEC Filing","media":"Reuters","content":"<html><body>Nov 4 (Reuters) - Novavax Inc <nvax.o>::<br/>*<a href=\"https://laohu8.com/S/0A3S.UK\">NOVAVAX INC</a> - FDA APPROVES TRANSFER OF NUVAXOVID AUTHORIZATION TO SANOFI - SEC FILING<br/>*NOVAVAX INC - NUVAXOVID MARKETING AUTHORIZATION TRANSFER TRIGGERS $25 MILLION PAYMENT FROM SANOFI TO NOVAVAX - SEC FILING<br/>*NOVAVAX INC:  ANTICIPATES RECEIPT OF MILESTONE PAYMENT FROM SANOFI IN Q1 OF 2026<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 04-NOV-202511:15:24 GMT</nvax.o></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax - FDA Approves Transfer Of Nuvaxovid Authorization To Sanofi - SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax - FDA Approves Transfer Of Nuvaxovid Authorization To Sanofi - SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-20 00:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>Nov 4 (Reuters) - Novavax Inc <nvax.o>::<br/>*<a href=\"https://laohu8.com/S/0A3S.UK\">NOVAVAX INC</a> - FDA APPROVES TRANSFER OF NUVAXOVID AUTHORIZATION TO SANOFI - SEC FILING<br/>*NOVAVAX INC - NUVAXOVID MARKETING AUTHORIZATION TRANSFER TRIGGERS $25 MILLION PAYMENT FROM SANOFI TO NOVAVAX - SEC FILING<br/>*NOVAVAX INC:  ANTICIPATES RECEIPT OF MILESTONE PAYMENT FROM SANOFI IN Q1 OF 2026<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 04-NOV-202511:15:24 GMT</nvax.o></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDbxtSSV:1","article_id":"2584592567","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584592567","pubTimestamp":1763569858,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Nov 4 (Reuters) - Novavax Inc ::*NOVAVAX INC - FDA APPROVES TRANSFER OF NUVAXOVID AUTHORIZATION TO SANOFI - SEC FILING*NOVAVAX INC - NUVAXOVID MARKETING AUTHORIZATION TRANSFER TRIGGERS $25 MILLION PAY","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BK4588":"碎股","BK4568":"美国抗疫概念","BK4547":"WSB热门概念","BK4585":"ETF&股票定投概念","BK4139":"生物科技"},"translate_title":"Novavax-FDA批准将Nuvaxovid授权转让给赛诺菲-SEC备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"Nov 4 (Reuters) - Novavax Inc ::*NOVAVAX INC - FDA APPROVES TRANSFER OF NUVAXOVID AUTHORIZATION TO SANOFI - SEC FILING*NOVAVAX INC - NUVAXOVID MARKETING AUTHORIZATION TRANSFER TRIGGERS $25 MILLION PAYMENT FROM SANOFI TO NOVAVAX - SEC FILING*NOVAVAX INC:  ANTICIPATES RECEIPT OF MILESTONE PAYMENT FROM SANOFI IN Q1 OF 2026  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 04-NOV-202511:15:24 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584592567","isCrawlerRequest":true}